Litigation

Jazz Pharmaceuticals, Inc. et al. v. Amneal Pharmaceuticals LLC

settled

2:13-cv-00391

Filed
2013-01-18
Terminated
2018-10-15

Patents at issue (1)

Summary

Consolidated D.N.J. Xyrem action in which the '306 patent was folded in and construed in the court's Markman decision. Terminated by Amneal settlement on Oct 15, 2018.

Case overview & background

Plain-language overview of the case: parties, accused product, patents at issue, and why the suit matters.

Save related patent research

Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).

Key legal developments & outcome

Major rulings, motions, claim construction, settlements, and the present posture or final disposition.

Save related patent research

Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).

Plaintiff representatives

Counsel of record for the plaintiff(s): attorneys, firms, and roles (lead counsel, of counsel, local counsel).

Save related patent research

Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).

Defendant representatives

Counsel of record for the defendant(s): attorneys, firms, and roles (lead counsel, of counsel, local counsel).

Save related patent research

Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).